Colon Cancer Patients with Close Family History Do Better

Colon cancer patients with a first-degree relative who also had colon cancer have a significantly better prognosis. In a recent study, even after all risk factors were taken into consideration, they had less chance of cancer recurring and less chance of dying than people without…

Read Full Post

KRAS Made No Difference in Stage III Outcome

Patients with stage III colon cancer didn’t do better or worse if their tumor had mutated KRAS. Studying KRAS in the tumors of about half the patients in a large clinical trial of chemotherapy for stage III colon cancer, researchers found no differences in disease-free,…

Read Full Post

Surgery at NCI Centers Shows Better Survival

Patients who had surgery for colon or rectal cancer performed at a National Cancer Institute Designated Center had less risk of death immediately after surgery and better long-term survival. Looking at nearly 34,000 people who had surgery for colon cancer and 8,600 who had rectal…

Read Full Post

KRAS Status Doesn't Impact Treatment with 5-FU Alone

While researchers have found that colorectal cancer tumors that have mutated KRAS genes don’t respond to treatment with EFGR inhibitors Erbitux®(cetuximab) and Vectibix™(panitumumab), is the same thing true for other drugs? 5-FU (fluorouracil) is the backbone of most colorectal cancer treatment, given alone or in…

Read Full Post